Table 3.

Correlation and Bland-Altman Analysis of MDCT and MRI

Parameters			Correlation Coefficient (r)	Linear Regression Equation	Signifficance Level (p)	mean Difference (bias)	Standard Deviation (SD)	95% Confidence interval for mean
Infarct size	(% L Vmass)	Total	0.70	y = 0.9 x + 9.4	<0.0001	−7.5	4.27	0.8 to −15.9
		week 12	0.37	y = 0.5 x + 14.1	0.16	−7.5	5.23	3.0 to −18.0
		week 24	0.89	y = 1.0 x + 7.5	<0.0001	−7.5	3.06	−1.7 to −13.3
		placebo	0.44	y = 0.5 x + 15.4	0.09	−7.4	4.22	1.7 to −16.5
		MSC	0.82	y = 1.1 x + 6.1	<0.001	−7.6	4.07	0.2 to −15.4
Total infarct volume	(cc)	Total	0.81	y = 1.3 x + 1.9	<0.0001	−3.2	1.71	0.3 to −6.6
		week 12	0.68	y = 1.2 x + 2.3	0.004	−3.0	1.77	0.3 to −6.4
		week 24	0.87	y = 1.3 x + 1.9	<0.0001	−3.3	1.76	0.3 to −6.9
		placebo	0.73	y = 1.1 x + 2.7	0.001	−3.3	1.94	0.4 to −7.0
		MSC	0.86	y = 1.5 x + 1.2	<0.0001	−3.0	1.53	0.3 to −6.2
LV ejection fraction	(%)	Total	0.90	y = 1.1 x − 3.2	<0.0001	−0.9	3.81	6.6 to −8.5
		week 12	0.87	y = 1.1 x − 2.4	<0.0001	−0.9	3.69	6.1 to −8.0
		week 24	0.92	y = 1.1 x − 3.5	<0.0001	−0.9	4.19	7.3 to −9.1
		placebo	0.88	y = 1.4 x − 12.1	<0.0001	0.3	3.43	7.6 to −7.0
		MSC	0.91	y = 1.0 x − 3.6	<0.0001	−2.2	3.78	5.0 to −9.6
ED volume	(ml)	Total	0.82	y = 0.7 x + 19.3	<0.0001	−0.02	6.63	15.9 to −16.0
		week 2	0.84	y = 0.6 x + 23.6	<0.001	−1.2	5.90	15.7 to −18.0
		week 24	0.81	y = 0.8 x + 12.2	<0.001	1.1	7.44	16.3 to −14.1
		placebo	0.81	y = 0.7 x + 18.5	<0.001	−3.1	6.38	11.1 to −17.3
		MSC	0.81	y = 0.7 x + 15.9	<0.001	3.0	7.10	18.8 to −12.7

Total: n=32; week 12, week 24, placebo, MSC: n=16